452 related articles for article (PubMed ID: 21658023)
1. Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.
Wang Y
Br J Pharmacol; 2012 Feb; 165(3):603-21. PubMed ID: 21658023
[TBL] [Abstract][Full Text] [Related]
2. Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis.
Wu G; Li H; Zhou M; Fang Q; Bao Y; Xu A; Jia W
Diabetes Metab Res Rev; 2014 Sep; 30(6):447-56. PubMed ID: 24214285
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition.
Liu JT; Song E; Xu A; Berger T; Mak TW; Tse HF; Law IK; Huang B; Liang Y; Vanhoutte PM; Wang Y
Br J Pharmacol; 2012 Jan; 165(2):520-31. PubMed ID: 21740414
[TBL] [Abstract][Full Text] [Related]
4. Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice.
Song E; Fan P; Huang B; Deng HB; Cheung BM; Félétou M; Vilaine JP; Villeneuve N; Xu A; Vanhoutte PM; Wang Y
J Am Heart Assoc; 2014 Apr; 3(2):e000837. PubMed ID: 24721803
[TBL] [Abstract][Full Text] [Related]
5. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.
Choi KM; Kim TN; Yoo HJ; Lee KW; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM
Clin Endocrinol (Oxf); 2009 Apr; 70(4):569-74. PubMed ID: 18710473
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin (NGAL) as a new biomarker for non--acute kidney injury (AKI) diseases.
Giasson J; Li GH; Chen Y
Inflamm Allergy Drug Targets; 2011 Aug; 10(4):272-82. PubMed ID: 21539515
[TBL] [Abstract][Full Text] [Related]
7. Human obesity and endothelium-dependent responsiveness.
Campia U; Tesauro M; Cardillo C
Br J Pharmacol; 2012 Feb; 165(3):561-73. PubMed ID: 21895631
[TBL] [Abstract][Full Text] [Related]
8. Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.
Jang Y; Lee JH; Wang Y; Sweeney G
Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):194-9. PubMed ID: 21689137
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.
Park CG; Choi KM
Clin Exp Hypertens; 2014; 36(7):478-83. PubMed ID: 24491219
[TBL] [Abstract][Full Text] [Related]
10. Microvascular responsiveness in obesity: implications for therapeutic intervention.
Bagi Z; Feher A; Cassuto J
Br J Pharmacol; 2012 Feb; 165(3):544-60. PubMed ID: 21797844
[TBL] [Abstract][Full Text] [Related]
11. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
[TBL] [Abstract][Full Text] [Related]
12. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
13. [The role of neutrophil gelatinase-associated lipocalin (NGAL) in the glycolipid metabolism and inflammation].
Zhu RT; Gong JP
Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):198-201. PubMed ID: 23019923
[No Abstract] [Full Text] [Related]
14. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin-2: pro- or anti-apoptotic?
Kehrer JP
Cell Biol Toxicol; 2010 Apr; 26(2):83-9. PubMed ID: 19160065
[TBL] [Abstract][Full Text] [Related]
16. Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease.
Payne GA; Kohr MC; Tune JD
Br J Pharmacol; 2012 Feb; 165(3):659-69. PubMed ID: 21545577
[TBL] [Abstract][Full Text] [Related]
17. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
18. In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL.
Rauen T; Weiskirchen R; Floege J
Nephrol Dial Transplant; 2011 Feb; 26(2):445-7. PubMed ID: 21273240
[No Abstract] [Full Text] [Related]
19. Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein.
Hoo RL; Yeung DC; Lam KS; Xu A
Expert Rev Endocrinol Metab; 2008 Jan; 3(1):29-41. PubMed ID: 30743783
[TBL] [Abstract][Full Text] [Related]
20. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
Schinzari F; Tesauro M; Cardillo C
J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
